5th International Cardiac Sarcoidosis Symposium

Clinicians, families, and communities who support patients with sarcoidosis need clear, practical education that helps them understand the disease, manage symptoms, navigate treatment, and maintain quality of life. The condition is complex and often unpredictable, so education must be comprehensive, ongoing, and tailored to each person’s organ involvement and disease severity.  The continuing medical education activity will address the role of PET, MRI, and serum markers in diagnosis; risk stratification; immunosuppressants; management of ventricular arrhythmia; and long-term complications.

For pricing information, see pricing tab below.

• Additional Info
• Agenda
• Pricing
• Speakers
• Location
• Accreditation & Credit Statements

Dates and Times

Start: 3/6/2026 8:00 AM
End: 3/6/2026 1:00 PM

Objectives

At the conclusion of this activity, participants will be able to:

1. Recognize the role of PET and MRI for diagnosis of cardiac sarcoidosis.
2. Review role of serum biomarkers for diagnosis of cardiac sarcoidosis.
3. Identify role of prolonged ambulatory rhythm monitoring for cardiac sarcoidosis.
4. Discuss risk stratification for the need of pacing and defibrillation therapy.
5. Explain the role of immunosuppressants for treatment of cardiac sarcoidosis.
6. Describe management of ventricular arrhythmia in patients with cardiac sarcoidosis.
7. Review surveillance for long-term complications of cardiac sarcoidosis.
8. Identify association of cardiac sarcoidosis and advanced heart failure and pulmonary hypertension.
9. Describe role of multidisciplinary approach for management of cardiac sarcoidosis.

Agenda

Pricing

Tier	Price
Physician, attending in person	$0.00
Physician participating online	$0.00
Physician Assistant attending in person	$0.00
Physician Assistant participating in person	$0.00
Advanced Practice Provider, attending in person	$0.00
Advanced Practice Provider participating online	$0.00
Nurse/Nurse Practitioner attending in person	$0.00
Nurse/Nurse Practitioner, participating online	$0.00
Other attending in person	$0.00
Other participating online	$0.00

Speakers

• Muhammad Afzal, MBBS
  • Role of Holter, MCT and ILR for arrhythmia surveillance and management – Implications of AV Block and non-sustained VT identified during ambulatory monitoring
• David Birnie, MD
  • Lessons from the CHASM – rational for the Use of Cardiac
• Elliott Crouser, MD
  • How to choose and follow immunosuppressant agents in the management of systemic sarcoidosis?
• Richard Gumina, MD
  • Welcome and Introduction
• Rami Kahwash, MD
  • Navigating the diagnosis and treatment of cardiac sarcoidosis in the acute setting
• Steven Kalbfleisch, MD
  • Closing remarks and vision for future
  • Determining which cardiac sarcoidosis patients require device therapy
• Jordana Kron, MD
  • Insights from the Cardiac Sarcoidosis Consortium
• Vaiibhav Patel, MD
  • Sarcoidosis is a great mimicker. Distinction of sarcoidosis from other cardiomyopathies
• Arindam Singha, MD
  • When should a non-cardiologist suspect cardiac sarcoidosis and refer to cardiology?
• Blair Suter, MD
  • Appropriate ordering and interpretation of PET scan in patients with suspected cardiac sarcoidosis
• Raul Weiss, MD
  • Ventricular arrhythmias in cardiac sarcoidosis
• Karolina Zareba, MD
  • Role of cardiac MRI to diagnose and risk stratify cardiac sarcoidosis.

Location

The Ohio State University Wexner Medical Center
Biomedical Research Tower
460 W. 10th Avenue, Level CL
Columbus, OH 43210

Accreditation Statement

The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The Ohio State University designates this live activity for a maximum of 4.25 AMA PRA Category 1 Credit(s) ^™. Physicians should only claim credit commensurate with the extent of their participation in the activity.